Contineum Therapeutics, Inc. Class A Common Stock (CTNM) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$13.27
Day's range
$14.48

Contineum Therapeutics Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
SUVRETTA CAPITAL MANAGEMENT, LLC 08/14/2026 2.84 M $46.57 M   0.00% 7.58%
JUPITER TOPCO LLC 08/14/2026 2.73 M $44.77 M   100.00% 7.30%
BLACKROCK, INC. 08/07/2026 2.06 M $33.83 M   208.52% 5.51%
JOHNSON & JOHNSON 08/06/2026 1.98 M $32.44 M   0.00% 5.28%
FRANKLIN RESOURCES INC 08/13/2026 1.84 M $30.14 M   0.00% 4.91%
BALYASNY ASSET MANAGEMENT L.P. 08/14/2026 1.52 M $24.96 M   -9.66% 4.06%
VANGUARD CAPITAL MANAGEMENT LLC 08/13/2026 1.32 M $21.66 M   8.83% 3.53%
PERCEPTIVE ADVISORS LLC 08/14/2026 1.26 M $20.58 M   0.00% 3.35%
FMR LLC 08/13/2026 1.04 M $17.05 M   27.64% 2.78%
MILLENNIUM MANAGEMENT LLC 08/14/2026 931.71 K $15.27 M   -39.32% 2.49%
GREAT POINT PARTNERS LLC 08/14/2026 921.48 K $15.10 M   15.16% 2.46%
LONGAEVA PARTNERS L.P. 08/14/2026 812.76 K $13.32 M   11.02% 2.17%
IKARIAN CAPITAL, LLC 08/14/2026 807.87 K $13.24 M   0.00% 2.16%
SECTORAL ASSET MANAGEMENT INC 08/14/2026 727.59 K $11.93 M   0.00% 1.94%
GEODE CAPITAL MANAGEMENT, LLC 08/12/2026 693.19 K $11.36 M   145.78% 1.85%
HHLR ADVISORS, LTD. 08/14/2026 669.34 K $10.97 M   0.00% 1.79%
RED TREE MANAGEMENT, LLC 07/22/2026 638.16 K $10.46 M   0.00% 1.70%
VERSANT VENTURE MANAGEMENT, LLC 08/12/2026 542.63 K $8.89 M   0.00% 1.45%
GOLDMAN SACHS GROUP INC 08/14/2026 497.26 K $8.15 M   61.92% 1.33%
BOXER CAPITAL MANAGEMENT, LLC 08/14/2026 494.00 K $8.10 M   0.00% 1.32%
STATE STREET CORP 09/22/2026 425.90 K $6.98 M   320.53% 1.14%
CITADEL ADVISORS LLC 09/02/2026 396.35 K $6.50 M   13.18% 1.06%
ADAGE CAPITAL PARTNERS GP, L.L.C. 08/14/2026 328.00 K $5.38 M   100.00% 0.88%
SILVERARC CAPITAL MANAGEMENT, LLC 08/13/2026 296.14 K $4.85 M   -1.85% 0.79%
ADAR1 CAPITAL MANAGEMENT, LLC 08/14/2026 278.96 K $4.57 M   0.83% 0.74%
NORTHERN TRUST CORP 08/13/2026 277.80 K $4.55 M   321.37% 0.74%
SQUADRON CAPITAL MANAGEMENT LLC 08/14/2026 260.00 K $4.26 M   100.00% 0.69%
BOOTHBAY FUND MANAGEMENT, LLC 08/14/2026 222.33 K $3.64 M   0.00% 0.59%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 08/14/2026 214.08 K $3.51 M   48.66% 0.57%
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. 08/14/2026 214.08 K $3.51 M   100.00% 0.57%
ISHARA INVESTMENTS LP 08/14/2026 205.00 K $3.36 M   44.37% 0.55%
SPHERA FUNDS MANAGEMENT LTD. 08/14/2026 183.48 K $3.01 M   5.76% 0.49%
QUBE RESEARCH & TECHNOLOGIES LTD 08/14/2026 182.41 K $2.99 M   -21.55% 0.49%
VANGUARD PORTFOLIO MANAGEMENT LLC 08/13/2026 180.30 K $2.96 M   100.00% 0.48%
DIMENSIONAL FUND ADVISORS LP 08/11/2026 178.67 K $2.93 M   198.06% 0.48%
VANGUARD FIDUCIARY TRUST CO 08/13/2026 177.28 K $2.91 M   15.17% 0.47%
WELLINGTON MANAGEMENT GROUP LLP 08/14/2026 150.80 K $2.47 M   171.17% 0.40%
CASDIN CAPITAL, LLC 08/14/2026 148.33 K $2.43 M   0.00% 0.40%
EVERSEPT PARTNERS, LP 08/14/2026 148.02 K $2.43 M   1.10% 0.40%
UBS GROUP AG 08/13/2026 130.64 K $2.14 M   -43.30% 0.35%
DIADEMA PARTNERS LP 08/14/2026 119.73 K $1.96 M   100.00% 0.32%
MARSHALL WACE, LLP 08/13/2026 118.06 K $1.93 M   -47.83% 0.32%
TREXQUANT INVESTMENT LP 08/14/2026 88.48 K $1.45 M   85.31% 0.24%
VERDAD ADVISERS, LP 08/14/2026 81.01 K $1.33 M   -5.83% 0.22%
BNP PARIBAS ARBITRAGE, SNC 08/13/2026 78.92 K $1.29 M   97.90% 0.21%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 08/14/2026 75.56 K $1.24 M   -79.67% 0.20%
SCHONFELD STRATEGIC ADVISORS LLC 08/14/2026 69.44 K $1.14 M   100.00% 0.19%
RENAISSANCE TECHNOLOGIES LLC 08/13/2026 67.30 K $1.10 M   -3.03% 0.18%
BANK OF NEW YORK MELLON CORP 08/06/2026 65.60 K $1.08 M   100.00% 0.18%
ACUTA CAPITAL PARTNERS, LLC 08/14/2026 63.10 K $1.03 M   100.00% 0.17%

Contineum Therapeutics Inc. institutional Ownership - FAQ's

During the previous two years, 128 institutional investors and hedge funds held shares of Contineum Therapeutics Inc.. The most heavily invested institutionals were:

SUVRETTA CAPITAL MANAGEMENT, LLC: 2.84 M

Jupiter Topco LLC: 2.73 M

BlackRock, Inc.: 2.06 M

JOHNSON & JOHNSON: 1.98 M

FRANKLIN RESOURCES INC: 1.84 M

BALYASNY ASSET MANAGEMENT L.P.: 1.52 M

82.10% of Contineum Therapeutics Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 35.18 M shares in the last 24 months. This purchase volume represents approximately $476.32 M in transactions.